Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Recursion Pharmaceuticals
< Previous
1
2
Next >
Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion updates L(earnings) call on August 8th to 8:30 am ET / 6:30 am MT
August 08, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th
August 05, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock
June 26, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Announces Proposed Offering of Class A Common Stock
June 26, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Participate in Upcoming Investor Conferences
June 03, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
May 29, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
May 24, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry
May 13, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
May 09, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
May 02, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Participate in Upcoming Investor Conferences
May 01, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program
April 30, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Participate in Upcoming Investor Conference
April 02, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Publishes Annual Environmental, Social and Governance Report
March 26, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
March 01, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Participate in Upcoming Investor Conferences
March 01, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
February 27, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Host Public L(earnings) Call on February 27
February 20, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Altitude Lab Startups Raise Over $120M in Capital
January 24, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
January 08, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
January 03, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
December 20, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Bayer and Recursion Focus Research Collaboration on Oncology
November 09, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
November 09, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Participate in Upcoming Investor Conference
November 02, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Participate in Upcoming Investor Conferences
September 05, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection
September 05, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds
August 08, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results
August 08, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit